TMCI TREACE MEDICAL CONCEPTS, INC.
P/E
--
Forward P/E
-5.035294
Price/Sales
1.3557643
Beta
1.486
Div Yield
0.0%
Market Cap
--
Company Analysis
Latest News
Treace Medical's third quarter 2026 EPS beat while revenue missed on product mix shift
Treace Medical Concepts reported third quarter 2026 revenue of $48.3 million, a 4% year-over-year decrease that fell short of analyst estimates. However, the...
Treace Medical Concepts, Inc. Q3 2026 Earnings Preview: What Analysts Expect on November 06, 2026
For the third quarter of 2026, analysts anticipate Treace Medical Concepts will report revenue of $51.8 million and an EPS of -$0.25, with the current stock...